Cui Wei, Liu Sa, Yang Min, Zhang Ting, Cai Lun, Qiu Shu-Lan, Zheng Jiao, Miao Yan-Ju, Zhao Li-Min, Du Jie
Beijing Anzhen Hospital Affiliated to Capital University of Medicine Beijing Institute of Heart Lung and Blood Vessel Disease, Beijing 100029, China.
Zhongguo Zhong Yao Za Zhi. 2013 Apr;38(7):1036-40.
To explore the inhibitory effect of combined administration of bear bile powder (BBP) and cyclophosphamide (Cytoxan, CTX) on colorectal cancer liver metastasis by regulating tumor promotion inflammation microenvironment.
The CRC liver metastasis mode in mice was established through in situ spleenic injection of SL4 tumor cells into spleens. The mice were randomly divided into 5 groups: the model group, the CTX (80 mg x kg(-1)) treatment group, the CTX + BBP high dose (300 mg x kg(-1)) group, the CTX + BBP middle dose (150 mg x kg(-1)) group and the CTX + BBP low dose (75 mg x kg(-1)) group. Mice were orally administered with drugs for 12 days, and sacrificed on the 13'h day for weighing their spleens and lives, HE staining, and immunofluorescence analysis. Their peripheral blood, and metastatic tumor in spleens and lives were analyzed with flow cytometry.
Spleen and liver weights of the: CTX treatment group and other doses groups were significantly lower than that of the model group. HE staining and immunofluorescence analysis showed that lymphocyte infiltration was detected in normal tissues, and macrophages infiltration was observed around the tumor tissues. Flow cytometry analysis showed that the number of T-lymphocytes in peripheral blood of different doses groups were much higher than that of the CTX treatment group (P < 0.05), with the rise in the ratio of CD4/CD8; the total number of lymphocytes in spleen cell suspension increased in different doses groups, compared to the CTX treatment group, with notable increase in B cells (P < 0.05) and significant decrease in CD11b, F4/80 cells (P < 0.05). The combined treatment showed less monocyte macrophages in liver metastasis than that of the CTX treatment group.
The combined treatment of bear bile powder and cyclophosphamide has the effect in not only protecting liver and increase immunity, but also in anti-inflammation and antitumor by regulating tumor microenvironment and reducing the collection of mononuclear macrophages. Particularly, the combined administration of low dose of bear bile powder and CTX shows the most significant effect in reducing inflammatory cell infiltration.
探讨熊胆粉(BBP)与环磷酰胺(CTX)联合给药通过调节肿瘤促炎微环境对结直肠癌肝转移的抑制作用。
通过将SL4肿瘤细胞原位注射到小鼠脾脏中建立小鼠结直肠癌肝转移模型。将小鼠随机分为5组:模型组、CTX(80mg·kg⁻¹)治疗组、CTX + BBP高剂量(300mg·kg⁻¹)组、CTX + BBP中剂量(150mg·kg⁻¹)组和CTX + BBP低剂量(75mg·kg⁻¹)组。小鼠口服给药12天,于第13天处死,称取脾脏和肝脏重量,进行HE染色及免疫荧光分析。用流式细胞术分析其外周血以及脾脏和肝脏中的转移瘤。
CTX治疗组及其他剂量组的脾脏和肝脏重量均显著低于模型组。HE染色及免疫荧光分析显示,正常组织中检测到淋巴细胞浸润,肿瘤组织周围观察到巨噬细胞浸润。流式细胞术分析表明,不同剂量组外周血中T淋巴细胞数量均高于CTX治疗组(P < 0.05),CD4/CD8比值升高;与CTX治疗组相比,不同剂量组脾细胞悬液中淋巴细胞总数增加,B细胞显著增加(P < 0.05),CD11b、F4/80细胞显著减少(P < 0.05)。联合治疗组肝转移中的单核巨噬细胞比CTX治疗组少。
熊胆粉与环磷酰胺联合治疗不仅具有保护肝脏和增强免疫力的作用,还能通过调节肿瘤微环境、减少单核巨噬细胞聚集发挥抗炎和抗肿瘤作用。特别是低剂量熊胆粉与CTX联合给药在减少炎症细胞浸润方面效果最为显著。